Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Living PlatformTSE:7091 +1.73%70 EV-to-EBIT is 13.40 as of Aug. 29, 2026, which is 51% below its 10-year median of 27.60. GuruFocus rates TSE:7091 with a GF Score™ of 70/100 and a GF Value™ of 円1,486.46 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Living Platform ranks better than 59.58% on this metric.
The historical rank and industry rank for Living Platform's EV-to-EBIT or its related term are showing as below:
TSE:7091'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.1 Med: 27.6 Max: 376.25
Current: 13.4
During the past 9 years, the highest EV-to-EBIT of Living Platform was 376.25. The lowest was 13.10. And the median was 27.60.
TSE:7091's EV-to-EBIT is ranked better than 59.58% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.78
vs TSE:7091: 13.40
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Living Platform's Enterprise Value for the quarter that ended in Mar. 2026 was 円10,588 Mil.
Living Platform's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円787 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Living Platform EV-to-EBIT Related Terms
Living Platform EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Living Platform's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Living Platform's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Living Platform EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Living Platform's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Living Platform's EV-to-EBIT falls into.
Living Platform's current Enterprise Value is 円10,536 Mil.
Living Platform's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円787 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Living Platform (TSE:7091) has a EV-to-EBIT of 13.40 as of Aug. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Living Platform and its competitors. This is 51% below median its historical median of 27.60. Over the past decade, Living Platform's EV-to-EBIT has ranged from 13.10 to 376.25. According to the industry distribution chart, Living Platform ranks #194 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 40.4%.
Is Living Platform's EV-to-EBIT too high?
Living Platform's current EV-to-EBIT of 13.40 is 51% below median its 10-year median of 27.60. Over the past 10 years, this metric has ranged from a low of 13.10 to a high of 376.25. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. Living Platform's value of 13.40 is 15.1% below this industry median. Based on the distribution chart, Living Platform ranks #194 out of 480 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Living Platform has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Living Platform's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Living Platform ranks #194 out of 480 companies for EV-to-EBIT. This puts Living Platform in the upper half of its industry. The industry median EV-to-EBIT is 15.78. Living Platform's value of 13.40 is 15.1% below this benchmark. Historically, Living Platform's own EV-to-EBIT has ranged from 13.10 to 376.25 over the past decade. While the company's 10-year median is 27.60 vs. the industry median of 15.78, Living Platform has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Living Platform's current EV-to-EBIT of 13.40 is 15.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Living Platform and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Living Platform's current EV-to-EBIT is 13.40, which is 51% below median its own 10-year median of 27.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Living Platform stock overvalued right now?
Based on GuruFocus' analysis, Living Platform (TSE:7091) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,486.46, compared to a current price of 円1,295.00 — trading 12.9% below its estimated fair value. The current EV-to-EBIT is 13.40, which is 51% below median its 10-year median of 27.60 and 15.1% below the Healthcare Providers & Services industry median of 15.78. Living Platform's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Living Platform (TSE:7091), the current EV-to-EBIT is 13.40 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Living Platform (TSE:7091) Overvalued in 2026?
Based on GuruFocus' analysis, Living Platform stock appears to be undervalued.
The current stock price of 円1,295.00 is trading 12.9% below its estimated GF Value™ of 円1,486.46.
GuruFocus considers Living Platform to be Modestly Undervalued.
Key valuation signals for TSE:7091:
EV-to-EBIT: 13.40 (51% below median its 10-year median of 27.60)
GF Value™: 円1,486.46 vs. price of 円1,295.00 (12.9% below fair value)
Industry Position: 15.1% below the Healthcare Providers & Services median (#194 of 480)
No single metric tells the full story. See the TSE:7091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Living Platform Ltd is engaged in providing nursing care, childcare, and support for people with disabilities. The company's services include paid nursing home care, Elderly housing with service, Visiting care, Regular patrol, ad hoc care nurs, ing care, Home-visit nursing, Home care support, Small multifunctional home care, among others. The Group operates in a single segment, the Life Care Business.
70GF Score
Get the complete analysis for TSE:7091
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7091 has been successfully added to your 
